Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo ; volume:17 ; number:1 ; day:17 ; month:2 ; year:2019 ; pages:1 ; date:12.2019
BMC medicine ; 17, Heft 1 (17.2.2019), 1, 12.2019
- Urheber
-
Berk, Michael
Turner, Alyna
Malhi, Gin S.
Ng, Chee H.
Cotton, Susan M.
Dodd, Seetal
Samuni, Yuval
Tanious, Michelle
McAulay, Claire
Dowling, Nathan
Sarris, Jerome
Owen, Lauren
Waterdrinker, Astrid
Smith, Deidre
Dean, Olivia M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-019-1280-2
- URN
-
urn:nbn:de:101:1-2019031322244307559910
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Berk, Michael
- Turner, Alyna
- Malhi, Gin S.
- Ng, Chee H.
- Cotton, Susan M.
- Dodd, Seetal
- Samuni, Yuval
- Tanious, Michelle
- McAulay, Claire
- Dowling, Nathan
- Sarris, Jerome
- Owen, Lauren
- Waterdrinker, Astrid
- Smith, Deidre
- Dean, Olivia M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Moving towards a population health approach to the primary prevention of common mental disorders
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
The DSM-5: Hyperbole, Hope or Hypothesis?
Pathways to new drug discovery in neuropsychiatry
Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)
An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?